In a human ovarian cancer study, it was found that the overexpression of XPO1 in the cytoplasm was prominently related to advanced tumor stage, poor differentiation and a higher mitotic rate, while higher XPO1 expression in the nucleus was associated with cyclooxygenase-2 expression and worse OS [42]. This evidence concerns the gene PTGS2 and ovarian cancer.